¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"drug delivery system"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • drug therapy
    ¾à¹°¿ä¹ý
  • drug tolerance
    ¾à¹°³»¼º, ¾à¹°ÀúÇ×¼º
  • drug treatment
    ¾à¹°Ä¡·á
  • drug trial
    ¾à¹°½ÃÇè
  • drug utilization review
    ¾à¹°»ç¿ë°ËÅä
  • drug-fast
    ¾à¹°³»¼º-
  • drug-induced
    ¾à¹°À¯¹ß-
  • drug-induced hemolysis
    ¾à¹°À¯¹ß¿ëÇ÷
  • drug-induced hemolytic anemia
    ¾à¹°À¯¹ß¿ëÇ÷ºóÇ÷
  • drug-induced hepatitis
    ¾à¹°À¯¹ß°£¿°
  • drug-induced immune complex
    ¾à¹°À¯¹ß¸é¿ªº¹ÇÕü
  • drug-induced jaundice
    ¾à¹°À¯¹ßȲ´Þ
  • drug-induced purpura
    ¾à¹°À¯¹ßÀÚ»ö¹Ý
  • drug-induced retinopathy
    ¾à¹°À¯¹ß¸Á¸·º´(Áõ)
  • drug-induced rhinitis
    ¾à¹°À¯¹ßÄÚ¿°, ¾à¹°À¯¹ßºñ¿°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • distric health system
    Áö¿ªº¸°Çü°è
  • dual foil system
    ÀÌÁß¹Ú¸·±¸Á¶
  • dynamic system
    µ¿Àû°èÅë
  • ecological system
    »ýŰè
  • electro transfer system
    ÀüÀÚÀü´Þ°è, ÀüÀÚ¿î¹Ýü
  • electro-optical system
    Àü±â±¤Çкм®°è
  • endocrine system
    ³»ºÐºñ°èÅë
  • exhaust system
    ¹èÃâÀåÄ¡, ¹è±â½Äȸ·Î
  • exteroceptive nervous system
    ¿Ü¼ö¿ë½Å°æ°è
  • family system theory
    °¡Á·Ã¼°è·Ð
  • gas disposal system
    °¡½ºÃ³¸®ÀåÄ¡
  • gate control system
    °ü¹®Á¶Á¤ÀåÄ¡
  • general system theory
    ÀϹÝü°è·Ð
  • genital system
    »ý½Ä°èÅë
  • genitourinary system
    ºñ´¢»ý½Ä°èÅë
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • primary signal system
    ÀÏÂ÷½ÅÈ£°è(ìéó­ãáûÜ Í§).
  • primary signalling system
    ÀÏÂ÷Àû¡¡½Åȣü°è
  • primitive duct system
    ¿ø½Ã°ü°èÅë
  • projective system
    Åõ»çü°è
  • real time system
    ½Ç½Ã°£ ü°è
  • reciprocal system
    »ó¹Ý°è(ßÓÚãͧ).
  • recirculating system
    Àç¼øÈ¯(¹æ)½Ä .
  • redox system
    »êȭȯ¿ø°è(ß«ûùü»êªÍ§).
  • registration system
    ½Å°íÁ¦µµ(Ëà˭̡̬).
  • remote afterloading system,RALS
    ¿ø°ÝÁ¶ÀÛÈÄÀåÁø¹ý
  • renal collecting system
    ½ÅÁýÇÕ°ü°èÅë(ãìó¢ùêηͧ÷Ö).
  • renal collecting system
    ½ÅÁýÇÕ°ü°èÅë
  • renal depressor system
    ½Å°­¾Ð°è.
  • renal pressor system
    ½Å½Â¾Ð°è(¡­ã°äâͧ).
  • renin angiotensin system
    ·¹´Ñ¾ÈÁö¿ÀÅٽŰè(¡­Í§).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
  • drug-induced cholestais
    ¾àÁ¦¼º ´ãÁó¿ïü.
  • drug-induced cholestasis
    ¾àÁ¦¼º ´ãÁó¿ïü.
  • drug-induced hemolysis
    ¾àÁ¦À¯¹ß¼º ¿ëÇ÷
  • drug-induced hemolytic anemia
    ¾à¹°À¯Àμº ¿ëÇ÷¼ººóÇ÷
  • drug-induced hepatitis
    ¾à¹°¼º °£¿°(¡­°£¿°).
  • drug-induced hepatitis
    ¾à¹° [¼ÒÈ­]¾à¹°¼º °£¿°(¡­ÊÜæú).
  • drug-induced hepatitis
    ¾à¹° ¼ÒÈ­¾à¹°¼º °£¿°(¡­ÊÜæú).
  • drug-induced immune complex
    ¾àÁ¦À¯¹ß¼º ¸é¿ªº¹ÇÕü
  • drug-induced lupus
    ¾à¹°À¯¹ß·çǪ½º
  • drug-induced nystagmus
    ¾à¹°¾ÈÁø
  • drug-induced psychosis
    ¾à¹°À¯¹ß Á¤½ÅÁõ
  • drug-induced purpura
    ¾à¹° À¯¹ß ÀÚ¹Ý(º´)(í¹Úè
  • drug-induced rhinitis =rhinitis medicamentosa <³ª
    ¾à¹°(¼º) ºñ¿°
  • drug-induced systemic lupus erythematosus
    ¾à¹°À¯¹ß Àü½Å¼ºÈ«¹Ý¼º ·çǪ½º
  • drug-induced vasculitis
    ¾à¹° À¯¹ß Ç÷°ü¿°
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
NSFTD normal spontaneous full-term delivery
NSVD normal spontaneous vaginal delivery
NVD nausea, vomiting, and diarrhea; neck vein distention; neovascularization of the disk; neurovesicle d...
O2D oxygen delivery
RDI recommended daily intake; respiratory disturbance index; rupture-delivery interval
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 12
NHSDA National Household Survey of Drug Abuse
NIDA National Institute of Drug Abuse
NDA New Drug Application
NSAID Non Steroidal Anti-Inflammatory Drug
PDA Parenteral drug abusers
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • hypothalamopituitary system
    ½Ã»ó ÇϺΠ³úÇϼöü°è
  • hypothalamus pituaitary system
    ½Ã»ó ÇϺΠ³úÇϼöü°è
  • immune system
    ¸é¿ª °èÅë, ¸é¿ª°è
    °¨¿°À̳ª Áúº´À¸·ÎºÎÅÍ ½Åü¸¦ ¹æ¾îÇϴµ¥ °ü¿©ÇÏ´Â ¿©·¯ ¼¼Æ÷¿Í Àå±â Áý´Ü.
  • immunologic system
    ¸é¿ª°è
    ¼¼Æ÷ ¼ººÐ ¹× ºÐÀÚ ¼ººÐÀÇ º¹ÇÕ Ã¼°è·Î¼­ ÀÌÀÇ ÀÏÂ÷ ±â´ÉÀº Àڱ⸦ ºñÀÚ±â·ÎºÎÅÍ ±¸º°ÇÏ°í ¿ÜºÎ »ý¹° ¶Ç´Â ¹°Áú¿¡ ´ëÇØ ¹æ¾îÇÏ´Â °ÍÀÌ´Ù.
  • implant system
    ÀÓÇöõÆ® ½Ã½ºÅÛ
  • improved classificaion system
    °³¼±µÈ ºÐ·ù ü°è
  • kinesodic system
    ô¼ö ¿îµ¿°è
  • kinetic system
    ¿îµ¿°è
    ³ú, °©»ó¼±, ºÎ½Å, °£, ÃéÀå µîÀÇ ±â°ü°èÅëÀ¸·Î, ÀáÀç·ÂÀ» ¿îµ¿°ú ¿­·Î º¯È­½ÃŰ´Â ±â´ÉÀ» ³ªÅ¸³½´Ù. ´Éµ¿Àû ¿îµ¿À» ÀÏÀ¸Å³ ¼ö ÀÖ´Â ½Å°æ±Ù°è.
  • lacrimal system
    ´«¹° ±â°ü
  • length monitoring system
    ±æÀÌ °¨Áö°è
  • lymphatic system
    ¸²ÇÁ°è
    °¨¿°À̳ª Áúº´°ú ½Î¿ì´Â ¼¼Æ÷¸¦ ¸¸µé°Å³ª ÀúÀåÇÏ´Â Á¶Á÷°ú Àå±â. °ñ¼ö, ºñÀå, Èä¼±, ±×¸®°í ¸²ÇÁÀý µîÀÌ ¸²ÇÁ°èÀÇ ´ëÇ¥Àû Àå±âÀÌ´Ù. ¸²ÇÁ°è¿¡´Â ÀÌ·¯ÇÑ ¿©·¯ Á¶Á÷°ú Àå±â¸¦ ¿¬°áÇÏ´Â Åë·Î Áï ¸²ÇÁ°üÀÌ ÀÖÀ¸¸ç À̸¦ ÅëÇØ ¸²ÇÁ°¡ ¿î¹ÝµÈ´Ù.
  • lymphoreticular system
    ¸²ÇÁ ¼¼¸Á ³»Çǰè
  • masticatory musculoskeletal system
    ÀúÀÛ±Ù °ñ°Ý°è
  • masticatory system
    ÀúÀÛ°è
    Ä¡¾Æ, Ä¡ÁÖ Á¶Á÷, ¾Ç°ñ, ÃøµÎÇϾǰüÀý, ÀúÀÛ±Ù ÀÔ¼ú, Çô ¹× À̵é Á¶Á÷°ú °ü·ÃµÈ Ç÷°ü, ½Å°æµé·Î ÀÌ·ç¾îÁø ±â´ÉÀû ´ÜÀ§.
  • mating system
    ±³¹è ½Ã½ºÅÛ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 12
p blood-group system A blood group related to the abo, lewis and I systems. at least five different erythrocyte antigens are possible, some very rare, others almost universal. Multiple alleles are involved in this blood group.
(12 Dec 1998)
renin-angiotensin-aldosterone system The hormones, renin, angiotensin, and aldosterone work together to regulate blood pressure. A sustained fall in blood pressure causes the kidney to release renin. This is converted to angiotensin in the circulation. Angiotensin then raises blood pressure directly by arteriolar constriction and stimulates adrenal gland to produce aldosterone which promotes sodium and water retention by kidney, such that blood volume and blood pressure increase.
(05 Mar 2000)
renin-angiotensin system <physiology> A system consisting of renin, angiotensin-converting enzyme, and angiotensin II.
Renin, an enzyme produced in the kidney, acts on angiotensinogen, an alpha-2 globulin produced by the liver, forming angiotensin I. The converting enzyme contained in the lung acts on angiotensin I in the plasma converting it to angiotensin II, the most powerful directly pressor substance known. It causes contraction of the arteriolar smooth muscle and has other indirect actions mediated through the adrenal cortex.
(25 Jun 1999)
centimeter-gram-second system The scientific system of expressing the fundamental physical units of length, mass, and time, and those units derived from them, in centimeters, grams, and seconds; currently being replaced by the International System of Units based on the meter, kilogram, and second.
(05 Mar 2000)
reproductive system In women, the organs that are directly involved in producing eggs and in conceiving and carrying babies.
(12 Dec 1998)
pedal system Efferent fibres connecting the forebrain with more caudal structures.
(05 Mar 2000)
central nervous system <anatomy, neurology> Pertaining to the brain, cranial nerves and spinal cord. It does not include muscles or peripheral nerves.
In invertebrates, the central nervous system is composed of the segmental ganglia of the ventral nerve cord together with the fused ganglia or brain at the anterior end.
Acronym: CNS
(12 Jan 1998)
central nervous system agents A class of drugs producing both physiological and psychological effects through a variety of mechanisms. They can be divided into "specific" agents, e.g., affecting an identifiable molecular mechanism unique to target cells bearing receptors for that agent, and "non-specific" agents, those producing effects on different target cells and acting by diverse molecular mechanisms. Those with non-specific mechanisms are generally further classed according to whether they produce behavioural depression or stimulation. Those with specific mechanisms are classed by locus of action or specific therapeutic use.
(12 Dec 1998)
central nervous system depressants A very loosely defined group of drugs that tend to reduce the activity of the central nervous system. The major groups included here are ethyl alcohol, anaesthetics, hypnotics and sedatives, narcotics, and tranquillising agents (antipsychotics and antianxiety agents).
(12 Dec 1998)
central nervous system infections Diseases of the central nervous sytem collectively, caused by pathogenic organisms.
(12 Dec 1998)
central nervous system neoplasms Neoplasms located in the brain, spinal cord, or meninges.
(12 Dec 1998)
central nervous system stimulants A loosely defined group of drugs that tend to increase behavioural alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here.
(12 Dec 1998)
glycogen debranching enzyme system 1,4-alpha-d-glucan-1,4-alpha-d-glucan 4-alpha-d-glucosyltransferase/dextrin 6 alpha-d-glucanohydrolase. An enzyme system having both 4-alpha-glucanotransferase (ec 2.4.1.25) and amylo-1,6-glucosidase (ec 3.2.1.33) activities. As a transferase it transfers a segment of a 1,4-alpha-d-glucan to a new 4-position in an acceptor, which may be glucose or another 1,4-alpha-d-glucan. As a glucosidase it catalyses the endohydrolysis of 1,6-alpha-d-glucoside linkages at points of branching in chains of 1,4-linked alpha-d-glucose residues. Amylo-1,6-glucosidase activity is deficient in glycogen storage disease type III.
(12 Dec 1998)
respiratory system The organs that are involved in breathing. These include the nose, throat, larynx, trachea, bronchi, and lungs.
(12 Dec 1998)
respiratory system abnormalities Congenital structural abnormalities of the respiratory system.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 12
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 12
ÅëÇÕ°Ë»ö ¿Ï·á